한국어
English
日本語
中文(简体)
Tavalisse 150 mg (Fostamatinib Disodium Hydrate)
189.3mg
Tablet · Prescription medication
JW Pharmaceutical Corp.
Postamatinib sodium hydrate is used as a treatment to improve thrombocytopenia.
MFDS ingredient code M285160
Postamatinib sodium hydrate is a drug used for the treatment of thrombocytopenic disorders, a synthetic medicine that has a mechanism of inhibiting specific enzymes. It aims to increase the platelet count in the blood and reduce the risk of bleeding.
This ingredient blocks important kinase enzymes in the signaling pathway, reducing platelet destruction and promoting platelet production. As a result, the platelet count increases, improving blood coagulation function.
Approved uses differ by product. Check each product's information for its actual use.
Unlike other platelet enhancers, postamatinib acts as a specific kinase inhibitor, directly regulating immune-mediated platelet destruction. This may lead to effectiveness in patients who do not respond to existing treatments.
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Even with the same ingredient, dosage and approved uses can differ by strength, dosage form and combined ingredients. Check each product's information before taking it.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
Product approval information is based on drug information provided by the Ministry of Food and Drug Safety.
Ingredient and class descriptions are not part of MFDS data and were written separately by Cashdoc.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.
